6
6 Ahn S, Woo JW, Lee K, Park SY. HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation. J Pathol Transl Med. 2020;54(1):34-44. http://dx.doi.org/10.4132/jptm.2019.11.03. PMid:31693827. http://dx.doi.org/10.4132/jptm.2019.11.0...
|
20 |
≥70 |
BL |
SPC |
- |
+ |
PR+ve |
Low grade |
1 case: Lung |
24
24 Duprez R, Wilkerson PM, Lacroix-triki M, et al. Immunophenotypic and genomic characterisation of papillary carcinomas of the breast. J Pathol. 2012;226(3):427-41. http://dx.doi.org/10.1002/path.3032. PMid:22025283. http://dx.doi.org/10.1002/path.3032...
|
34 |
≥60 |
BL+ nd |
niSPC |
CC |
+ |
ER+ve PR+ve |
NA |
NR |
25
25 Tsang WY, Chan JK. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol. 1996;20(8):921-43. http://dx.doi.org/10.1097/00000478-199608000-00002. PMid:8712293. http://dx.doi.org/10.1097/00000478-19960...
|
05 |
60 |
BL |
BPTC |
- |
NA |
NA |
NA |
NR |
26
26 Eusebi V, Damiani S, Ellis I, Azzopardi J, Rosai J. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 5 cases. Am J Surg Pathol. 2003;27(8):1114-8. http://dx.doi.org/10.1097/00000478-200308000-00008. PMid:12883243. http://dx.doi.org/10.1097/00000478-20030...
|
01 |
64 |
BL |
BPTC |
DCIS |
NA |
NA |
Papillary Thyroid carcinoma |
NR |
27
27 Cameselle-Teijeiro J, Abdulkader I, Barreiro-Morandeira F, Ruiz-Ponte C, Reyes-Santias R, Chavez E. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: a case report. Int J Surg Pathol. 2006;14(1):79-84. http://dx.doi.org/10.1177/106689690601400116. http://dx.doi.org/10.1177/10668969060140...
|
21 |
66 |
BL |
iSPC + niSPC |
NEC |
+ |
ER+ve PR+ve |
NA |
NR |
8
8 Nassar H. Solid papillary carcinoma of the breast. Pathol Case Rev. 2009;14(4):157-61. http://dx.doi.org/10.1097/PCR.0b013e3181b6ad5d. http://dx.doi.org/10.1097/PCR.0b013e3181...
|
20 |
≥60 |
Benign lesions +invasive Ca |
SPC |
NEC |
+ |
ER+ve PR+ve |
NA |
NR |
7
7 Maluf H, Koerner F. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol. 1995;19(11):1237-44. http://dx.doi.org/10.1097/00000478-199511000-00003. PMid:7573685. http://dx.doi.org/10.1097/00000478-19951...
|
58 |
70 |
Benign lesions +invasive Ca |
SPC Grade 1 |
NEC |
+ |
ER+ve |
NA |
22 cases: lymph node 1 case: Distant metastasis |
28
28 Wei B, Bu H, Chen H, Zhang H, Li X. Clinicopathological study of solid papillary carcinoma of breast. Zhonghua Bing Li Xue Za Zhi. 2006;35(10):589-93. PMid:17134565.
|
11 |
48-78 |
BL |
niSPC grade 2-3 |
IDC |
NA |
NA |
NA |
7 cases: Lymph node |
29
29 Nicolas MM, Wu Y, Middleton LP, Gilcrease MZ. Loss of myoepithelium is variable in solid papillary carcinoma of the breast. Histopathology. 2007;51(5):657-65. http://dx.doi.org/10.1111/j.1365-2559.2007.02849.x. PMid:17927587. http://dx.doi.org/10.1111/j.1365-2559.20...
|
04 |
45-80 |
BL + thyroid nodule |
BPTC |
- |
NA |
variable |
NA |
1 case: Lymph node |
30
30 Tosi AL, Ragazzi M, Asioli S, et al. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 4 cases with evidence of malignant potential. Int J Surg Pathol. 2007;15(1):14-9. http://dx.doi.org/10.1177/1066896906295689. PMid:17172492. http://dx.doi.org/10.1177/10668969062956...
|
01 |
66 |
BL |
BPTC |
IPC |
NA |
Triple Negative |
Intraductal papilloma |
NR |
31
31 Chang S, Fleiszer D, Mesurolle BEI, Khoury M, Omeroglu A. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma. Breast J. 2009;15(5):531-5. http://dx.doi.org/10.1111/j.1524-4741.2009.00773.x. PMid:19594763. http://dx.doi.org/10.1111/j.1524-4741.20...
|
22 |
≥60 |
BL |
iSPC + niSPC |
|
+ |
ER/PR+ve |
NA |
NR |
32
32 Zhong D, Sun P, Liang Z. Clinicopathological features of solid papillary carcinoma in breast. J Diag Path. 2010;17:165-8.
|
30 |
60-70 |
BL |
iSPC + niSPC |
|
+ |
ER+ve PR+ve |
Low-grade l |
NR |
33
33 Rakha EA, Gandhi N, Climent F, et al. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis. Am J Surg Pathol. 2011;35(8):1093-103. http://dx.doi.org/10.1097/PAS.0b013e31821b3f65. PMid:21753694. http://dx.doi.org/10.1097/PAS.0b013e3182...
|
01 |
65 |
BL |
BPTC |
- |
NA |
NA |
NA |
NR |
34
34 Masood S, Davis C, Kubik M. Changing the term “breast tumor resembling the tall cell variant thyroid of papillary carcinoma” to “tall cell variant of papillary breast carcinoma”. Adv Anat Pathol. 2012;19(2):108-10. http://dx.doi.org/10.1097/PAP.0b013e318249d090. PMid:22313838. http://dx.doi.org/10.1097/PAP.0b013e3182...
|
02 |
44, 55 |
BL |
iSPC |
- |
NA |
Not done |
Papillary carcinoma |
NR |
35
35 Leena JB, Kini RG, Amber S. Invasive (solid) papillary carcinoma of the breast: a report of two cases. J Clin Diagn Res. 2013;7(6):1150-1. PMid:23905125.
|
32 |
67 |
BL + nd |
niSPC |
- |
+ |
ER+ve PR+ve |
NA |
1 case: Distant metastasis |
36
36 Zheng X, Ge R, Meng L, Liu C. Clinicopathological study of solid papillary carcinoma in the breast. China Oncol. 2014;24:208-11.
|
01 |
77 |
BL + nd |
BPTC |
DCIS |
NA |
Triple negative |
Intraductal papillary lesion |
NR |
37
37 Colella R, Guerriero A, Giansanti M, Sidoni A, Bellezza G. An additional case of breast tumor resembling the tall cell variant of papillary thyroid carcinoma. Int J Surg Pathol. 2015;23(3):217-20. http://dx.doi.org/10.1177/1066896914536222. PMid:24868004. http://dx.doi.org/10.1177/10668969145362...
|
13 |
51-70 |
- |
SPCRP |
- |
NA |
Variable |
NA |
NR |
38
38 Chiang S, Weigelt B, Wen H, et al. IDH2 mutations define a unique subtype of breast cancer with altered nuclear polarity. Cancer Res. 2016;76(24):7118-29. http://dx.doi.org/10.1158/0008-5472.CAN-16-0298. PMid:27913435. http://dx.doi.org/10.1158/0008-5472.CAN-...
|
13 |
58-79 |
BL |
BPTC |
- |
NA |
Triple Negative |
NA |
01 case: lymph node |
12
12 Joseph B, Shah B, Shi D. Solid papillary carcinoma of the breast: mammographic and ultrasound appearance with histopathologic correlation. Ann Reviwes Res. 2019;5(3):7-9. http://dx.doi.org/10.19080/ARR.2018.04.555662. http://dx.doi.org/10.19080/ARR.2018.04.5...
|
04 |
66-79 |
BL + nd |
SPC |
- |
+ |
Not done |
NA |
- |
39
39 Foschini MP, Asioli S, Foreid S, et al. Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms: a unique invasive tumor with indolent behavior. Am J Surg Pathol. 2017;41(7):887-95. http://dx.doi.org/10.1097/PAS.0000000000000853. PMid:28418993. http://dx.doi.org/10.1097/PAS.0000000000...
|
01 |
72 |
BL + nd |
iSPC + necrosis |
- |
+ |
ER+ve PR+ve |
NA |
Lymph node |
40
40 Şenel F, Karaman H, Eroǧlu M, Tuna Ö. Invasive papillary breast carcinoma, solid variant with neuroendocrine differentiation. Turk J Surg. 2015;33(4):302-4. http://dx.doi.org/10.5152/UCD.2015.3074. PMid:29260140. http://dx.doi.org/10.5152/UCD.2015.3074...
|
01 |
82 |
nd |
iSPC + pagetoid extension |
- |
+ |
Not done |
NA |
lymph node |
4
4 Mac Grogan G, Collins L, Lerwill M, Pakha E, Tan B. Solid papillary carcinoma (insitu and invasive). In: WHO Classification of Tumors Editorial Board, ed. Breast tumors. France: IARC Press; 2019. p. 63-5.
|
01 |
46 |
BL |
iSPC |
|
+ |
ER+ve PR-ve |
|
Lung, liver and bone metastasis |
This case |
01 |
65 |
BL + nd |
iSPC |
- |
+ |
ER+ve PR+ve |
suspicious for malignancy |
0 |